Furthermore, Lertrit et al reported in a randomized double-blind cross over study that daily oral ingestion of 200 mg encapsulated sucralose for 4 weeks decreased whole body and hepatic insulin sensitivities (Matsuda index and HOMA-IR, respectively) in 15 healthy volunteers without obesity (11 female). The gene discussed is INS; the disease is obesity disorder.